Patent Watch: Nutramax Targets Cannabis Combinatio
The application appears to cover formulations combining cannabis-derived material with one or more additional pharmacologically active components, with inflammation identified as a therapeutic focus. The published classification data suggest a…
Preventing Weight Regain with Procedural Intervention in GLP-1 Therapy
Procedural intervention weight regain prevention GLP-1 therapy offers a promising approach to sustain weight loss after stopping medication. Recent clinical trials show reduced weight rebound with adjunctive procedures. This strategy supports long-term…
GLP-1 Receptor Agonist Randomized Trial: Weight Loss and Regain Prevention
Weight regain prevention after GLP-1 therapy is a critical challenge in obesity management. This randomized trial explores adjunctive strategies to maintain weight loss. Understanding these approaches helps clinicians support long-term patient outcomes.
